Breast Neoplasms: all 12,820 studies
Page 92 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- A Sleep Intervention to Improve Outcomes Among Women at High Risk of Breast CancerCompletedNCT02613923Not applicable
- Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast CancerCompletedNCT02613026Phase 3
- Sienna+® Injection Time Study 4 ArmsStatus unknownNCT02612870Phase 4
- Axillary Radiotherapy for Early Stage Breast Cancer With Limited Positive Sentinel Lymph NodesStatus unknownNCT02612012
- Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer SurvivorsCompletedNCT02611544Not applicable
- A Study to Observe Treatment Patterns and Outcomes in Participants in Saudi Arabia With Human Epidermal Growth Factor Receptor 2 (HER2-Positive) Unresectable Locally Advanced or Metastatic Breast Cancer (LA/mBC)TerminatedNCT02611310
- Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron InjectionWithdrawnNCT02610920Early Phase 1
- Safety and Efficacy of Sentinel Node Biopsy Omission for Breast Cancer Patients Who Plan to Have Adjuvant ChemotherapyWithdrawnNCT02610621Phase 2
- Improving Cancer-Related Outcomes in Shift WorkersCompletedNCT02609373Not applicable
- Efficacy of Thoracic Paravertebral Block in the Reduction of Acute Post-surgical Pain in Patients With Breast CancerCompletedNCT02609321Phase 3
- Breast Reconstruction Outcomes With and Without StratticECompletedNCT02608593
- Evaluation of Diagnostic Accuracy of Contrast Enhanced Dual Energy Mammography Imaging in Comparison to CE-MRICompletedNCT02608281Not applicable
- [18F]FLT PET/CT in Rb+ Metastatic Breast CancerActive, not recruitingNCT02608216Phase 1
- Platinum Rechallenge in Patients With Platinum-sensitive mTNBCStatus unknownNCT02607215Phase 2
- Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast CancerCompletedNCT02605915Phase 1
- BreAst Cancer and Cardiotoxicity Induced by RAdioTherapy: the BACCARAT StudyCompletedNCT02605512Not applicable
- Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)Active, not recruitingNCT02605486Phase 1/2
- Surgical Intervention and Physiotherapy in Breast Cancer: Effects in Scapular Kinematics, Pain and Upper Limb FunctionCompletedNCT02604030Not applicable
- Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node MetastasesActive, not recruitingNCT02603679Phase 2
- Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium TrialActive, not recruitingNCT02603341Not applicable
- Efficacy Study of Clinical Nutrition to Treat Lung Neoplasms And Breast CarcinomaCompletedNCT02603016Not applicable
- 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer PatientsTerminatedNCT02602067Phase 1
- A Study of Delivering a Mindfulness App Intervention to Accompany Supportive Care Among Women With Breast CancerCompletedNCT02601794Not applicable
- Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular MarkersStatus unknownNCT02600442
- Effectiveness of a Psycho-educational Group (PEG) Intervention on Supportive Care and Survivorship Issues in Early-stage Breast Cancer Survivors Who Have Received Systemic TreatmentCompletedNCT02600299Phase 2
- PET-CT in the Initial Staging of Breast Cancer and in the Early Assessment of Response to Neoadjuvant ChemotherapyStatus unknownNCT02599974
- Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast CancerCompletedNCT02599714Phase 1
- Fear of Cancer Recurrence (FoR) Trajectory During Radiation TreatmentCompletedNCT02599506
- A Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast CancerCompletedNCT02599363Phase 1
- Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast CancerTerminatedNCT02598427Phase 1
- Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast CancerTerminatedNCT02598310Phase 2
- A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)Status unknownNCT02597868Not applicable
- Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast CancerStatus unknownNCT02597179
- TME Neoadjuvant Breast RegistryStatus unknownNCT02596724
- A Study of Mitoxantrone Hydrochloride Liposome Injection in Advanced Recurrent or Metastatic Breast CancerStatus unknownNCT02596373Phase 2
- A Study of Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast CancerCompletedNCT02595762
- Capecitabine in Metastatic Breast and GI CancersStatus unknownNCT02595320Phase 2
- Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast CancerStatus unknownNCT02595138Phase 3
- Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast CancerCompletedNCT02594371Phase 3
- Breast Surgery Recovery: The Clinical and Psychosocial Impact of THEYA Recovery RangeStatus unknownNCT02593890Not applicable
- The Registration Program of BRCA1/2 GeneStatus unknownNCT02593435
- Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast CancerCompletedNCT02593227Phase 2
- A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBCStatus unknownNCT02592746Phase 2
- Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive TumorsActive, not recruitingNCT02592083Phase 2
- Activity & Cognition After Treatment for Breast CancerCompletedNCT02592070Not applicable
- Genetic Alteration After Systemic Treatment in Breast CancerStatus unknownNCT02591966
- Nutrition, Physical Activity, and Cognition in Breast Cancer SurvivorsCompletedNCT02591316
- Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast CancerCompletedNCT02590458Early Phase 1
- Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid TumorStatus unknownNCT02587689Phase 1/2
- Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRICompletedNCT02587663Not applicable
- Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer.TerminatedNCT02585388Phase 2
- Effect of Exercise Training in Autonomic Modulation in Breast Cancer PatientsCompletedNCT02584712Not applicable
- Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer PatientsCompletedNCT02583828Not applicable
- Fluorescence Guided Surgery in Breast CancerCompletedNCT02583568Phase 1/2
- Taxane Chemotherapy and Nail Toxicity in Women With Breast Cancer; Stage Two: Evaluation of InterventionsStatus unknownNCT02583204Not applicable
- Clinical Research of 18F-Alfatide Ⅱ PET/CT in Breast CancerTerminatedNCT02582801Phase 1
- Walking Affecting Immunology and Quality of Life of Breast Cancer PatientsCompletedNCT02581956Not applicable
- An Intervention Programme to Reduce Cognitive Impairment Due to CancerTerminatedNCT02581709Not applicable
- Study on SBRT for Inoperable Lung and Liver Oligometastases From Breast CancerStatus unknownNCT02581670Not applicable
- CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)CompletedNCT02580448Phase 1/2
- Evaluation Of CanADVICE+®M-Health System To Support Breast Cancer Patients Receiving CapecitabineCompletedNCT02580396Not applicable
- Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant RadiotherapyStatus unknownNCT02580279Phase 2
- A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsCompletedNCT02576431Phase 2
- Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of LumpectomyCompletedNCT02576106Not applicable
- Diagnosis of Pathological Complete Response by Minimal Invasive Biopsy After Neoadjuvant Chemotherapy in Breast CancerCompletedNCT02575612Not applicable
- Markers for Predicting Risk of Breast Cancer in Women of Different RacesWithdrawnNCT02574546
- Behavioral Weight and Symptom Management for Breast Cancer Survivors and PartnersCompletedNCT02574507Not applicable
- The Cardio-Oncology Breast Cancer StudyStatus unknownNCT02571894Not applicable
- Research and Analysis of the Mechanisms Involved in the Emergence of Breast Cancer Stem Cells (RepriM)TerminatedNCT02570100Not applicable
- Dose Escalation Study of HBI-8000 in Combination With Paclitaxel and Trastuzumab in Women With Advanced or Metastatic HER2+ Breast CancerWithdrawnNCT02569489Phase 1
- Feasibility and Impact of Group Interventions on Breast Cancer Patients Well-beingCompletedNCT02569294Not applicable
- Neoadjuvant Response-guided Treatment of HER2 Positive Breast CancerActive, not recruitingNCT02568839Phase 2/3
- Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)Active, not recruitingNCT02568267Phase 2
- Assessment of the Anesthetic Effect on the Activity of Immune Cell in Patient With Breast CancerCompletedNCT02567929Not applicable
- Muscle Loss and Fatigue as a Consequence of RadiotherapyActive, not recruitingNCT02567669
- Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney DysfunctionWithdrawnNCT02567396Phase 1
- Attitudes, Beliefs, and Preferences of Older Stage I-III Breast Cancer Survivors Towards Physical ActivityCompletedNCT02566408Not applicable
- ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid TumorsCompletedNCT02565758Phase 1
- Safety and Efficacy of Omission of Sentinel Node Biopsy in Patients With Estrogen-Positive Breast Cancer Over Age 65Active, not recruitingNCT02564848Not applicable
- Study of SM-88 in Advanced CancersWithdrawnNCT02562612Phase 1/2
- Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast CancerActive, not recruitingNCT02562118Phase 1/2
- The Preemptive Analgesic Efficacy of NefopamCompletedNCT02561468Not applicable
- PhysSurg-B : Physical Activity in Relation to Surgical Operations - Breast CancerCompletedNCT02560662Not applicable
- Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective AnalysisStatus unknownNCT02560311
- Study on Breast Cancer Patient Perspectives of ExerciseCompletedNCT02559362
- Evaluating Outcomes of Immediate Breast Reconstruction (POBRAD-M)Status unknownNCT02557906Not applicable
- Written Genetic Counseling and Mutation Analysis of BRCA1 and BRCA2 to Patients With Breast CancerCompletedNCT02557776Not applicable
- Breast-Specific Gamma Imaging and Locally Advanced Breast Cancer Undergoing Neoadjuvant ChemotherapyStatus unknownNCT02556684
- Abraxane in Treatment of Metastatic Breast CancerCompletedNCT02555696
- Breast Reconstruction and Body Map : Assessment by Functional MRI (REMASCO)CompletedNCT02553967Not applicable
- An Observational Study in Patients With Breast Cancer and Bone Metastases Receiving Ibandronate (Bondronat)CompletedNCT02553850
- Eribulin Treatment as 1st-line or 2nd-line Chemotherapy for HER2-negative Hormone-resistant Inoperable or Recurrent Metastatic Breast CancerCompletedNCT02551263
- Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast CancerCompletedNCT02549677Phase 4
- To Reverse ENDocrine Resistance Trial - PD 0332991 Monotherapy vs PD 0332991 in Combination With the Endocrine TherapyCompletedNCT02549430Phase 2
- Argon Plasma Coagulation Scalpel on Surgical Treatment of Breast CancerCompletedNCT02548338Phase 2/3
- Chimeric Antigen Receptor-Modified T Cells for Breast CancerWithdrawnNCT02547961Phase 1/2
- Breast Cancer Chemotherapy Risk Prediction Mathematical ModelStatus unknownNCT02547545
- ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)CompletedNCT02546934Phase 3
- Improved Breast Cancer Therapy (I-BCT-1) in the Neoadjuvant and Metastatic SettingActive, not recruitingNCT02546232Phase 2
- Supportive Care Questionnaires in Gathering Data on Unmet Needs and Health-Related Quality of Life in Latina Breast Cancer Survivors After Surgery, Chemotherapy, or Radiation TherapyCompletedNCT02545023